Pharmacogenomics in HRT: Personalizing Testosterone Therapy for Men with Hypogonadism
Reading Time: 2 minutes Introduction Hormone replacement therapy (HRT) has become a pivotal treatment modality for men experiencing hypogonadism, a condition characterized by low levels of testosterone. As the field of endocrinology advances, the integration of pharmacogenomics into HRT protocols offers a promising avenue for tailoring treatments to individual genetic profiles, thereby optimizing efficacy and minimizing adverse effects. Understanding Pharmacogenomics in HRT Pharmacogenomics, the study of how genes affect a person's response to drugs, is revolutionizing medical treatments across various specialties. In the context of HRT for men, pharmacogenomics can help predict how individuals will respond to testosterone replacement. Genetic variations can influence the...


